Superiority Trials in Invasive Aspergillosis: A Harsh Reality Check With the IA-DUET (HOVON502) Trial
Hanne Lamberink(Erasmus MC), Bart Rijnders(Rega Institute for Medical Research), Tom Lodewyck(AZ Sint-Jan), Ine Moors(Ghent University Hospital), Astrid Demandt(Maastricht University Medical Centre), Elena van Leeuwen-Segarceanu(St. Antonius Ziekenhuis), Maarten F. Corsten(Meander Medisch Centrum), Maya Hites(Université Libre de Bruxelles), Julien De Greef(Assistance Publique – Hôpitaux de Paris), Robina Aerts(KU Leuven), Katrien Lagrou(KU Leuven), Sophie Servais(University of Liège), Alexander Schauwvlieghe(AZ Sint-Jan), Johan Maertens(Universitair Ziekenhuis Leuven), Laurens Nieuwenhuizen(Radboud University Nijmegen), Sammy Huygens(Ghent University Hospital)
Cited by 3
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k